SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-559463
Filing Date
2016-04-27
Accepted
2016-04-27 16:07:05
Documents
6
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d333061ddefa14a.htm DEFA14A 34351
2 GRAPHIC g333061not1.jpg GRAPHIC 1000
3 GRAPHIC g333061not2.jpg GRAPHIC 1000
4 GRAPHIC g333061not3.jpg GRAPHIC 997
5 GRAPHIC g333061not4.jpg GRAPHIC 999
6 GRAPHIC g333061xbox.jpg GRAPHIC 4145
  Complete submission text file 0001193125-16-559463.txt   47287
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 161595398
SIC: 2834 Pharmaceutical Preparations